Lymphoma, Non-Hodgkin  >>  peripheral blood stem cell transplantation  >>  Phase 3
Welcome,         Profile    Billing    Logout  

7 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
peripheral blood stem cell transplantation / National Cancer Institute
NCT00004230: Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation

Completed
3
35
US
captopril, cyclophosphamide, autologous bone marrow transplantation, peripheral blood stem cell transplantation, radiation therapy
Northwestern University, National Cancer Institute (NCI)
Cancer
03/02
03/02
NCT00002835: Combination Chemotherapy in Treating Patients With Lymphoma

Completed
3
116
US
Bleomycin Sulfate (BLM), Blenoxane, BLM, Filgrastim (G-CSF), G-CSF, Neupogen, Recombinant Interferon Alfa, Carmustine, BiCNU, BiCNUI, Cisplatin (CDDP), Platinol, Platinol-AQ, Cyclophosphamide, Cytoxan, Neosar, Cytarabine (ARA-C), ARA-C, Cytosar, DepotCyt, Cytosine arabinosine hydrochloride, Etoposide (VP-16), VePesid, Idarubicin, Idamycin, Ifosfamide, Ifex, Leucovorin Calcium, Leucovorin, Citrovorum, Wellcovorin, Melphalan, Alkeran, Methotrexate, Methylprednisolone, Depo-Medrol, Medrol, Solu-Medrol, mitoxantrone hydrochloride (DHAD), mitoxantrone, Novantrone, Vincristine Sulfate, Peripheral Blood Stem Cell Transplantation, autologous peripheral blood stem cells, PBSC, Radiation Therapy, RT
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Lymphoma
02/04
02/04
NCT00003414: Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease

Completed
3
50
US
aldesleukin, recombinant interferon gamma, busulfan, cyclophosphamide, cyclosporine, peripheral blood stem cell transplantation, radiation therapy
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, National Cancer Institute (NCI)
Graft Versus Host Disease, Lymphoma
05/04
05/04
NCT00052923: Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma

Completed
3
427
US
filgrastim, rituximab, carmustine, cyclophosphamide, etoposide, peripheral blood stem cell transplantation, radiation therapy
Eastern Cooperative Oncology Group, National Cancer Institute (NCI), Cancer and Leukemia Group B
Lymphoma
06/06
 
SWOG 9438, NCT00002649: Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

Completed
3
206
US
aldesleukin, IL-2, Proleukin, recombinant human interleukin-2, recombinant interleukin-2, filgrastim, G-CSF, Neupogen, cyclophosphamide, CPM, CTX, Cytoxan, Endoxan, Endoxana, etoposide, EPEG, VP-16, VP-16-213, radiation therapy, irradiation, radiotherapy, therapy, radiation, peripheral blood stem cell transplantation, PBPC transplantation, PBSC transplantation, peripheral blood progenitor cell transplantation, transplantation, peripheral blood stem cell, bone marrow ablation with stem cell support
National Cancer Institute (NCI)
Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma
11/06
 
NCT00075478: Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Completed
3
87
US, Europe
Total-Body Irradiation, TBI, Total Body Irradiation, Whole-Body Irradiation, Fludarabine Phosphate, 2-F-ara-AMP, Beneflur, SH T 586, Mycophenolate Mofetil, Cellcept, MMF, Cyclosporine, 27-400, CsA, Neoral, OL 27-400, Sandimmun, Peripheral Blood Stem Cell Transplantation, PBPC transplantation, Peripheral Blood Progenitor Cell Transplantation, Peripheral Stem Cell Support, Peripheral Stem Cell Transplantation
Fred Hutchinson Cancer Center, National Heart, Lung, and Blood Institute (NHLBI), National Cancer Institute (NCI)
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Aggressive Non-Hodgkin Lymphoma, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Diffuse Large B-Cell Lymphoma, Hematopoietic and Lymphoid Cell Neoplasm, Indolent Non-Hodgkin Lymphoma, Mantle Cell Lymphoma, Myelodysplastic/Myeloproliferative Neoplasm, Plasma Cell Myeloma, Refractory Chronic Lymphocytic Leukemia, Refractory Hodgkin Lymphoma, Waldenstrom Macroglobulinemia
02/14
02/14
NCT00438958: Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases

Completed
3
230
US, Canada, RoW
filgrastim, allogeneic bone marrow transplantation, peripheral blood stem cell transplantation
The Canadian Blood and Marrow Transplant Group, National Cancer Institute (NCI)
Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Myelodysplastic Syndromes, Secondary Myelofibrosis
 
 

Download Options